Published in Diabet Med on February 01, 2000
Relationships between fat and bone. Osteoporos Int (2007) 2.51
Increased fat mass is associated with increased bone size but reduced volumetric density in pre pubertal children. Bone (2011) 1.05
Relationship between bone mineral density, leptin and insulin concentration in Brazilian obese adolescents. J Bone Miner Metab (2009) 1.01
Metal-on-metal hip prostheses and systemic health: a cross-sectional association study 8 years after implantation. PLoS One (2013) 1.00
Effects of physiological variations in circulating insulin levels on bone turnover in humans. J Clin Endocrinol Metab (2011) 0.97
The association of fasting insulin, glucose, and lipids with bone mass in adolescents: findings from a cross-sectional study. J Clin Endocrinol Metab (2012) 0.88
Associations of total and undercarboxylated osteocalcin with peripheral and hepatic insulin sensitivity and β-cell function in overweight adults. J Clin Endocrinol Metab (2013) 0.87
The association between bone mineral density and metabolic syndrome: a Korean population-based study. J Bone Miner Metab (2013) 0.83
Association Between Insulin Resistance and Bone Structure in Nondiabetic Postmenopausal Women. J Clin Endocrinol Metab (2016) 0.80
Abdominal adiposity, insulin and bone quality in young male rats fed a high-fat diet containing soybean or canola oil. Clinics (Sao Paulo) (2011) 0.79
Cytokines and Hormones That Contribute to the Positive Association between Fat and Bone. Front Endocrinol (Lausanne) (2014) 0.77
The association between the serum C-peptide level and bone mineral density. PLoS One (2013) 0.77
Higher Serum Insulin Concentrations Positively Influence the Bone Mineral Density in African American Adolescents. Br J Med Med Res (2013) 0.75
Insulin and bone health in young adults: The mediator role of lean mass. PLoS One (2017) 0.75
Renal osteodystrophy in the obesity era: Is metabolic syndrome relevant? PLoS One (2017) 0.75
Association of insulin resistance with near peak bone mass in the femur and lumbar spine of Korean adults aged 25-35: The Korean National Health and Nutrition Examination Survey 2008-2010. PLoS One (2017) 0.75
Association of lipid parameters and insulin resistance with bone health in South Korean adolescents. Osteoporos Int (2015) 0.75
Heritability of type II (non-insulin-dependent) diabetes mellitus and abnormal glucose tolerance--a population-based twin study. Diabetologia (1999) 3.64
Randomised controlled trial of structured personal care of type 2 diabetes mellitus. BMJ (2001) 3.12
The epidemic of type 2 diabetes is a statistical artefact. Diabetologia (2005) 2.41
Low birth weight is associated with NIDDM in discordant monozygotic and dizygotic twin pairs. Diabetologia (1997) 2.41
Concordance rates of insulin dependent diabetes mellitus: a population based study of young Danish twins. BMJ (1995) 2.40
Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus. J Clin Invest (1992) 1.96
Genetic versus environmental aetiology of the metabolic syndrome among male and female twins. Diabetologia (2001) 1.65
Impaired beta cell glucose sensitivity rather than inadequate compensation for insulin resistance is the dominant defect in glucose intolerance. Diabetologia (2010) 1.64
Impaired insulin-induced site-specific phosphorylation of TBC1 domain family, member 4 (TBC1D4) in skeletal muscle of type 2 diabetes patients is restored by endurance exercise-training. Diabetologia (2010) 1.57
Effects of insulin infusion on human skeletal muscle pyruvate dehydrogenase, phosphofructokinase, and glycogen synthase. Evidence for their role in oxidative and nonoxidative glucose metabolism. J Clin Invest (1987) 1.56
Insulin action and age. European Group for the Study of Insulin Resistance (EGIR). Diabetes (1996) 1.52
The new Danish Twin Register: establishment and analysis of twinning rates. Int J Epidemiol (1995) 1.50
Reduced glycogen synthase activity in skeletal muscle from obese patients with and without type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia (1991) 1.49
Impaired fasting glycaemia resembles impaired glucose tolerance with regard to cardiovascular risk factors: population-based, cross-sectional study of risk factors for cardiovascular disease. Diabet Med (2004) 1.49
Clinical impact of mild carbohydrate intolerance in pregnancy: a study of 2904 nondiabetic Danish women with risk factors for gestational diabetes mellitus. Am J Obstet Gynecol (2001) 1.47
Does zygosity influence the metabolic profile of twins? A population based cross sectional study. BMJ (1999) 1.46
Insulin sensitivity in pre-eclampsia. Br J Obstet Gynaecol (1998) 1.45
Twin study of genetic and environmental influences on glucose tolerance and indices of insulin sensitivity and secretion. Diabetologia (2003) 1.42
Twin study of genetic and environmental influences on adult body size, shape, and composition. Int J Obes Relat Metab Disord (2004) 1.39
GLUT4 is reduced in slow muscle fibers of type 2 diabetic patients: is insulin resistance in type 2 diabetes a slow, type 1 fiber disease? Diabetes (2001) 1.38
Independent influence of age on basal insulin secretion in nondiabetic humans. European Group for the Study of Insulin Resistance. J Clin Endocrinol Metab (1999) 1.37
Effect of the antilipolytic nicotinic acid analogue acipimox on whole-body and skeletal muscle glucose metabolism in patients with non-insulin-dependent diabetes mellitus. J Clin Invest (1991) 1.36
Morphometric documentation of abnormal intramyocellular fat storage and reduced glycogen in obese patients with Type II diabetes. Diabetologia (2001) 1.34
Triglyceride-induced diabetes associated with familial lipoprotein lipase deficiency. Diabetes (1999) 1.31
Expression of insulin regulatable glucose transporters in skeletal muscle from type 2 (non-insulin-dependent) diabetic patients. Diabetologia (1990) 1.30
On the determination of basal glucose production rate in patients with type 2 (non-insulin-dependent) diabetes mellitus using primed-continuous 3-3H-glucose infusion. Diabetologia (1990) 1.26
Impaired cellular insulin binding and insulin sensitivity induced by high-fructose feeding in normal subjects. Am J Clin Nutr (1980) 1.24
Lumbar vertebral body compressive strength evaluated by dual-energy X-ray absorptiometry, quantitative computed tomography, and ashing. Bone (1999) 1.22
Decreased activation of skeletal muscle glycogen synthase by mixed-meal ingestion in NIDDM. Diabetes (1988) 1.21
Age-dependent impact of zygosity and birth weight on insulin secretion and insulin action in twins. Diabetologia (2002) 1.19
Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patients. Troglitazone Study Group. Diabetologia (1996) 1.17
Insulin secretion, insulin action, and hepatic glucose production in identical twins discordant for non-insulin-dependent diabetes mellitus. J Clin Invest (1995) 1.17
A cellular model system of differentiated human myotubes. APMIS (2001) 1.15
Classification of newly diagnosed diabetic patients as insulin-requiring or non-insulin-requiring based on clinical and biochemical variables. Diabetes Care (1989) 1.13
Natural history and physiological determinants of changes in glucose tolerance in a non-diabetic population: the RISC Study. Diabetologia (2011) 1.13
No association between birth weight and Type 1 diabetes mellitus--a twin-control study. Diabet Med (2000) 1.11
Effect of physical training on mitochondrial respiration and reactive oxygen species release in skeletal muscle in patients with obesity and type 2 diabetes. Diabetologia (2010) 1.11
Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in Diabetes (RECORD): study design and protocol. Diabetologia (2005) 1.09
Rosiglitazone RECORD study: glucose control outcomes at 18 months. Diabet Med (2007) 1.08
Maternal and perinatal outcomes in 143 Danish women with gestational diabetes mellitus and 143 controls with a similar risk profile. Diabet Med (2000) 1.08
Plasma sCD36 is associated with markers of atherosclerosis, insulin resistance and fatty liver in a nondiabetic healthy population. J Intern Med (2011) 1.07
Changes in patient weight and the impact of antidiabetic therapy during the first 5 years after diagnosis of diabetes mellitus. Diabetologia (2006) 1.06
The pathogenic role of an insulin-receptor defect in diabetes mellitus of the obese. Diabetes (1978) 1.05
Insulin resistance in skeletal muscles in patients with NIDDM. Diabetes Care (1992) 1.05
Effects of insulin on kidney function and sodium excretion in healthy subjects. Diabetologia (1989) 1.05
Insulin receptor binding and receptor-mediated insulin degradation in human adipocytes. Diabetologia (1981) 1.04
A reduced number of insulin receptors in patients with Prader-Willi syndrome. Acta Endocrinol (Copenh) (1983) 1.03
Assessment of hepatic insulin action in obese type 2 diabetic patients. Diabetes (2001) 1.03
Effects of insulin on glucose turnover rates in vivo: isotope dilution versus constant specific activity technique. Metabolism (1996) 1.03
Prevalence and mortality of acute myocardial infarction in patients with diabetes. Diabetes Care (1985) 1.03
No evidence of a higher 10 year period prevalence of diabetes among 77,885 twins compared with 215,264 singletons from the Danish birth cohorts 1910-1989. Diabetologia (2011) 1.02
Hormone replacement therapy dissociates fat mass and bone mass, and tends to reduce weight gain in early postmenopausal women: a randomized controlled 5-year clinical trial of the Danish Osteoporosis Prevention Study. J Bone Miner Res (2003) 1.02
Increased insulin receptors after exercise in patients with insulin-dependent diabetes mellitus. N Engl J Med (1980) 1.01
Insulin analogues and severe hypoglycaemia in type 1 diabetes. Diabetes Res Clin Pract (2011) 1.01
Direct evidence of fiber type-dependent GLUT-4 expression in human skeletal muscle. Am J Physiol Endocrinol Metab (2000) 1.01
Hormonal replacement therapy reduces forearm fracture incidence in recent postmenopausal women - results of the Danish Osteoporosis Prevention Study. Maturitas (2000) 1.00
Transcriptional profiling of myotubes from patients with type 2 diabetes: no evidence for a primary defect in oxidative phosphorylation genes. Diabetologia (2008) 1.00
Multiple defects of both hepatic and peripheral intracellular glucose processing contribute to the hyperglycaemia of NIDDM. Diabetologia (1995) 1.00
Improved in vivo insulin effect during continuous subcutaneous insulin infusion in patients with IDDM. Diabetes (1984) 0.99
Human ATP synthase beta is phosphorylated at multiple sites and shows abnormal phosphorylation at specific sites in insulin-resistant muscle. Diabetologia (2009) 0.98
Decreased binding of insulin to its receptor in patients with congenital generalized lipodystrophy. N Engl J Med (1977) 0.98
Hyperglycaemia compensates for the defects in insulin-mediated glucose metabolism and in the activation of glycogen synthase in the skeletal muscle of patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia (1992) 0.97
Increased glucose effectiveness in normoglycemic but insulin-resistant relatives of patients with non-insulin-dependent diabetes mellitus. A novel compensatory mechanism. J Clin Invest (1994) 0.97
Age- and gender-related differences in vertebral bone mass, density, and strength. J Bone Miner Res (1999) 0.97
Variation in absorption of NPH insulin due to intramuscular injection. Diabetes Care (1990) 0.96
The antiviral 2',5'-oligoadenylate synthetase is persistently activated in type 1 diabetes. Clin Immunol (2000) 0.96
Altered basal and insulin-stimulated phosphotyrosine phosphatase (PTPase) activity in skeletal muscle from NIDDM patients compared with control subjects. Diabetologia (1996) 0.96
Proliferation conditions for human satellite cells. The fractional content of satellite cells. APMIS (2001) 0.96
Intramuscular versus subcutaneous injection of unmodified insulin: consequences for blood glucose control in patients with type 1 diabetes mellitus. Diabet Med (1990) 0.95
Cytokines and T-lymphocyte subsets in healthy post-menopausal women: estrogen retards bone loss without affecting the release of IL-1 or IL-1ra. Bone (1997) 0.94
Cost-effectiveness analyses of elective orthopaedic surgical procedures in patients with inflammatory arthropathies. Scand J Rheumatol (2011) 0.94
Effects of diet on the cellular insulin binding and the insulin sensitivity in young healthy subjects. Diabetologia (1978) 0.94
Weight history of patients with newly diagnosed Type 2 diabetes. Diabet Med (2008) 0.93
Reduced plasma adiponectin concentrations may contribute to impaired insulin activation of glycogen synthase in skeletal muscle of patients with type 2 diabetes. Diabetologia (2006) 0.92
Increased expression of 11beta-hydroxysteroid dehydrogenase type 1 in type 2 diabetic myotubes. Eur J Clin Invest (2005) 0.92
Insulin resistance in growth hormone-deficient adults: defects in glucose utilization and glycogen synthase activity. J Clin Endocrinol Metab (1996) 0.92
Increased insulin sensitivity and cellular insulin binding in obese diabetics following treatment with glibenclamide. Acta Endocrinol (Copenh) (1979) 0.91
Cytokines and bone loss in a 5-year longitudinal study--hormone replacement therapy suppresses serum soluble interleukin-6 receptor and increases interleukin-1-receptor antagonist: the Danish Osteoporosis Prevention Study. J Bone Miner Res (2000) 0.91
Pronounced blood glucose-lowering effect of the antilipolytic drug acipimox in noninsulin-dependent diabetes mellitus patients during a 3-day intensified treatment period. J Clin Endocrinol Metab (1994) 0.91
Clomipramine vs desipramine vs placebo in the treatment of diabetic neuropathy symptoms. A double-blind cross-over study. Br J Clin Pharmacol (1990) 0.90
Use of 360-degree assessment of residents in internal medicine in a Danish setting: a feasibility study. Med Teach (2007) 0.90
The chemokines CCL5, CCL2 and CXCL12 play significant roles in the migration of Th1 cells into rheumatoid synovial tissue. Scand J Immunol (2003) 0.90
Structured personal care of type 2 diabetes: a 19 year follow-up of the study Diabetes Care in General Practice (DCGP). Diabetologia (2013) 0.90
Glucose transporter expression in human skeletal muscle fibers. Am J Physiol Endocrinol Metab (2000) 0.89
Adult glucose metabolism in extremely birthweight-discordant monozygotic twins. Diabetologia (2012) 0.89
Diurnal profile of pancreatic polypeptide, pancreatic glucagon, gut glucagon and insulin in human morbid obesity. Int J Obes (1983) 0.89
Risk and mechanism of dexamethasone-induced deterioration of glucose tolerance in non-diabetic first-degree relatives of NIDDM patients. Diabetologia (1997) 0.89
Metabolic effects of lifestyle intervention in obese pregnant women. Results from the randomized controlled trial 'Lifestyle in Pregnancy' (LiP). Diabet Med (2014) 0.89
Metformin improves peripheral but not hepatic insulin action in obese patients with type II diabetes. Acta Endocrinol (Copenh) (1989) 0.88
Steroid-induced insulin resistance and impaired glucose tolerance are both associated with a progressive decline of incretin effect in first-degree relatives of patients with type 2 diabetes. Diabetologia (2012) 0.88